Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Terns Pharmaceuticals
company
Funding Round
Series C
Money Raised
$ 87M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Deepfield | - | Yes | - | Detail |
| Eli Lilly | - | Yes | - | Detail |
| Lilly Asia Ventures | - | - | - | Detail |
| OrbiMed | - | - | - | Detail |
| Samara Capital | - | - | - | Detail |
| Suvretta Capital Management | - | - | - | Detail |
| Vivo Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Oct 30, 2018 | Series B | $ 80M | Decheng Capital,Lilly Asia Ventures,etc. | Detail |
| Apr 4, 2018 | Series A | $ 30M | Lilly Asia Ventures | Detail |
